ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties G Xiong, Z Wu, J Yi, L Fu, Z Yang, C Hsieh, M Yin, X Zeng, C Wu, A Lu, ... Nucleic acids research 49 (W1), W5-W14, 2021 | 1179 | 2021 |
Association of inflammatory markers with the severity of COVID-19: A meta-analysis F Zeng, Y Huang, Y Guo, M Yin, X Chen, L Xiao, G Deng International Journal of Infectious Diseases 96, 467-474, 2020 | 694 | 2020 |
Procalcitonin levels in COVID-19 patients R Hu, C Han, S Pei, M Yin, X Chen International journal of antimicrobial agents 56 (2), 106051, 2020 | 345 | 2020 |
Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer M Yin, X Li, S Tan, HJ Zhou, W Ji, S Bellone, X Xu, H Zhang, AD Santin, ... The Journal of clinical investigation 126 (11), 4157-4173, 2016 | 335 | 2016 |
Clinical determinants for fatality of 44,672 patients with COVID-19 G Deng, M Yin, X Chen, F Zeng Critical Care 24, 1-3, 2020 | 306 | 2020 |
Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling T Zhang, X Wu, C Ke, M Yin, Z Li, L Fan, W Zhang, H Zhang, F Zhao, ... Journal of proteome research 12 (1), 505-512, 2013 | 194 | 2013 |
Ruscogenin attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway G Cao, N Jiang, Y Hu, Y Zhang, G Wang, M Yin, X Ma, K Zhou, J Qi, B Yu, ... International journal of molecular sciences 17 (9), 1418, 2016 | 170 | 2016 |
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements SM Zhang, WL Cai, X Liu, D Thakral, J Luo, LH Chan, MK McGeary, ... Nature 598 (7882), 682-687, 2021 | 145 | 2021 |
Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction M Yin, Y Guo, R Hu, WL Cai, Y Li, S Pei, H Sun, C Peng, J Li, R Ye, ... Nature communications 11 (1), 1833, 2020 | 123 | 2020 |
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics S Zhu, Y Guo, X Zhang, H Liu, M Yin, X Chen, C Peng Cancer letters 503, 240-248, 2021 | 113 | 2021 |
The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced … M Yin, F Zhao, G Lou, H Zhang, M Sun, C Li, Y Hou, X Li, F Meng, X Chen International Journal of Gynecologic Cancer 21 (1), 2011 | 102 | 2011 |
Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry T Zhang, X Wu, M Yin, L Fan, H Zhang, F Zhao, W Zhang, C Ke, G Zhang, ... Clinica Chimica Acta 413 (9-10), 861-868, 2012 | 96 | 2012 |
Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform L Fan, W Zhang, M Yin, T Zhang, X Wu, H Zhang, M Sun, Z Li, Y Hou, ... Acta oncologica 51 (4), 473-479, 2012 | 90 | 2012 |
A comprehensive analysis of metabolomics and transcriptomics in cervical cancer K Yang, B Xia, W Wang, J Cheng, M Yin, H Xie, J Li, L Ma, C Yang, A Li, ... Scientific reports 7 (1), 43353, 2017 | 80 | 2017 |
Occupational skin conditions on the front line: a survey among 484 Chinese healthcare professionals caring for Covid‐19 patients S Pei, Y Xue, S Zhao, N Alexander, G Mohamad, X Chen, M Yin Journal of the European Academy of Dermatology and Venereology 34 (8), e354, 2020 | 66 | 2020 |
CD34+ KLF4+ stromal stem cells contribute to endometrial regeneration and repair M Yin, HJ Zhou, C Lin, L Long, X Yang, H Zhang, H Taylor, W Min Cell reports 27 (9), 2709-2724. e3, 2019 | 66 | 2019 |
BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway G Deng, F Zeng, J Su, S Zhao, R Hu, W Zhu, S Hu, X Chen, M Yin Theranostics 10 (25), 11428, 2020 | 63 | 2020 |
MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1 T Ge, M Yin, M Yang, T Liu, G Lou Cellular physiology and biochemistry 34 (6), 2209-2220, 2014 | 62 | 2014 |
Involvement of Wnt, Eda and Shh at defined stages of sweat gland development CY Cui, M Yin, J Sima, V Childress, M Michel, Y Piao, D Schlessinger Development 141 (19), 3752-3760, 2014 | 60 | 2014 |
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression M Zhang, ZZ Liu, K Aoshima, WL Cai, H Sun, T Xu, Y Zhang, Y An, ... Science translational medicine 14 (630), eabf5473, 2022 | 59 | 2022 |